A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.

Estébanez, Miriam; Stella-Ascariz, Natalia; Mingorance, Jesús; Pérez-Valero, Ignacio; González-Baeza, Alicia; Bayón, Carmen; Lakatos, Botond; Borobia, Alberto; Arnalich, Francisco; Arribas, José R

Estébanez, Miriam; Stella-Ascariz, Natalia; Mingorance, Jesús; Pérez-Valero, Ignacio; González-Baeza, Alicia; Bayón, Carmen; Lakatos, Botond; Borobia, Alberto; Arnalich, Francisco; Arribas, José R.

Affiliation

Estébanez M; *HIV Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Microbiology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Psychiatry Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; and §Clinical Pharmacology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain (Dr Lakatos is now with Department of Infectious Diseases, Saint Laszlo Teaching Hospital of Semmelweis University, Budapest, Hungary).

J Acquir Immune Defic Syndr ; 67(4): 419-23, 2014 Dec 01.

Article in En | MEDLINE | ID: mdl-25197825

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: AIDS Dementia Complex / HIV Protease Inhibitors / Anti-HIV Agents / Antiretroviral Therapy, Highly Active Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google